News

People in high-deductible plans who buy drugs with big rebates will get the greatest savings from the move.

The FDA commissioner aimed particular criticism at giant pharmacy benefit managers for their role in hindering access to less-expensive versions of high-cost drugs.

The question of how information from medical records can be shared securely with patients and among different providers has long vexed the industry.

Purdue Pharma's decision to stop promoting its opioid drugs is being hailed as the first result of a judge's push for concrete solutions to a nationwide epidemic.

Three economists say their proposed Supplemental Transition Accounts for Retirement would provide a bridge to Social Security to help those who need to retire early.

Investors including nuns who manage an order's retirement funds asked Wells Fargo to produce evidence that its incentive programs are aligned with clients' interests.